v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (shares) at Jun. 25, 2023   124,794,000      
Balance at beginning of period at Jun. 25, 2023 $ 1,621.9 $ 0.2 $ 3,711.0 $ (2,064.2) $ (25.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (864.2)     (864.2)  
Net unrealized gain on available-for-sale securities 13.5       13.5
Tax withholding on vested equity awards (18.0)   (18.0)    
Stock-based compensation 105.5   105.5    
Issuance of shares under the employee stock purchase plan (in shares)   1,615,000      
Issuance of shares under the employee stock purchase plan 23.4   23.4    
Balance at end of period (shares) at Jun. 30, 2024   126,409,000      
Balance at end of period at Jun. 30, 2024 882.1 $ 0.2 3,821.9 (2,928.4) (11.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (1,609.2)     (1,609.2)  
Net unrealized gain on available-for-sale securities 7.8       7.8
Tax withholding on vested equity awards (3.9)   (3.9)    
Stock-based compensation 72.2   72.2    
Issuance of shares under the employee stock purchase plan (in shares)   1,440,000      
Issuance of shares under the employee stock purchase plan 8.7   8.7    
Issuance of shares under the at-the-market offering program, net of issuance costs (in shares)   27,794,000      
Issuance of shares under the at-the-market offering program, net of issuance costs $ 195.2   195.2    
Balance at end of period (shares) at Jun. 29, 2025 155,643,000 155,643,000      
Balance at end of period at Jun. 29, 2025 $ (447.1) $ 0.2 4,094.1 (4,537.6) (3.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 420.2     420.2  
Net unrealized gain on available-for-sale securities 0.8       0.8
Tax withholding on vested equity awards (in shares)   (382,000)      
Tax withholding on vested equity awards (0.6)   (0.6)    
Stock-based compensation (in shares)   1,218,000      
Stock-based compensation 71.6   71.6    
Cancellation of Predecessor equity (in shares)   (156,479,000)      
Cancellation of Predecessor equity (44.9) $ (0.2) (4,165.1) 4,117.4 3.0
Issuance of shares under the at-the-market offering program, net of issuance costs (in shares)   25,841,000      
Issuance of shares under the at-the-market offering program, net of issuance costs 569.1   569.1    
Substantial premium on 2L Convertible Notes 168.8   168.8    
Contingent Shares (Unissued) 19.2   19.2    
Balance at end of period (shares) at Sep. 29, 2025   25,841,000      
Balance at end of period at Sep. 29, 2025 $ 757.1 $ 0.0 757.1 0.0 0.0
Balance at beginning of period (shares) at Sep. 28, 2025 156,479,390        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Substantial premium on 2L Convertible Notes     168.8    
Balance at end of period (shares) at Sep. 29, 2025   25,841,000      
Balance at end of period at Sep. 29, 2025 $ 757.1 $ 0.0 757.1 0.0 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (415.8)        
Net unrealized gain on available-for-sale securities $ 0.0        
Balance at end of period (shares) at Jun. 28, 2026 52,162,000 52,162,000      
Balance at end of period at Jun. 28, 2026 $ 930.2 $ 0.1 1,345.9 (415.8) 0.0
Balance at beginning of period (shares) at Sep. 30, 2025   25,841,000      
Balance at beginning of period at Sep. 30, 2025 757.1 $ 0.0 757.1 0.0 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (415.8)     (415.8)  
Settlement of equity forward for common shares (in shares)   16,852,000      
Settlement of equity forward for common shares 292.0   292.0    
Contingent Shares (Issued) (in shares)   871,000      
Conversion of Convertible Notes (in shares)   5,269,000      
Conversion of Convertible Notes 63.6 $ 0.1 63.5    
Tax withholding on vested equity awards (1.2)   (1.2)    
Stock-based compensation (in shares)   79,000      
Stock-based compensation 21.8   21.8    
Reclassification of Renesas conversion option 87.9   87.9    
Reclassification of Renesas stock warrant liability 31.5   31.5    
Issuance of shares under the at-the-market offering program, net of issuance costs (in shares)   3,250,000      
Issuance of shares under the at-the-market offering program, net of issuance costs 57.7   57.7    
Proceeds from the issuance of warrants, net of issuance costs $ 35.6   35.6    
Balance at end of period (shares) at Jun. 28, 2026 52,162,000 52,162,000      
Balance at end of period at Jun. 28, 2026 $ 930.2 $ 0.1 $ 1,345.9 $ (415.8) $ 0.0